SCHEMBL22356356

SCHEMBL22356356

C=C(C)C(=O)OCCOc1cccc(Nc2nc(Nc3ccccc3)nc(Nc3cccc(OCCOC(=O)C(=C)C)c3)n2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RHOA P61586 1/20 0.46
SYK P43405 5/20 0.46
SIRT2 Q8IXJ6 4/20 0.43
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
TSHR P16473 1/20 0.43
JAK2 O60674 3/20 0.42
HDAC1 Q13547 3/20 0.42
HDAC6 Q9UBN7 3/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
HTT P42858 2/20 0.42
POLB P06746 1/20 0.42
APEX1 P27695 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
EGFR P00533 2/20 0.41
KDM4E B2RXH2 1/20 0.41
TAAR1 Q96RJ0 1/20 0.41
ITK Q08881 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22356361 1.00 RHOA (0.46) RHOASYKSIRT2NPC1RAB9A
SCHEMBL22356474 0.96 SYK (0.48) SYKNPC1RAB9ASMN1; SMN2JAK2
SCHEMBL22356359 0.96 SYK (0.51) RHOASYKSIRT2NPC1RAB9A
SCHEMBL22356365 0.92 SYK (0.54) SYKJAK2HDAC1HDAC6HTT
SCHEMBL22356472 0.92 SYK (0.54) SYKJAK2HDAC1HDAC6HTT
SCHEMBL22356345 0.90 RHOA (0.47) RHOASYKNPC1RAB9ASMN1; SMN2
SCHEMBL22356461 0.90 RHOA (0.47) RHOASYKNPC1RAB9ASMN1; SMN2
SCHEMBL22356362 0.90 HTT (0.50) NPC1RAB9ASMN1; SMN2TSHRMEN1
SCHEMBL22356357 0.90 HTT (0.50) NPC1RAB9ASMN1; SMN2TSHRMEN1
SCHEMBL22356370 0.86 SYK (0.44) RHOASYKNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200262798-A1 NOVEL TRIAZINE DERIVATIVE AND PHOTOSENSITIVE COMPOSITION COMPRISING SAME TREEEL CO., LTD (KR) 2020-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200262798-A1 NOVEL TRIAZINE DERIVATIVE AND PHOTOSENSITIVE COMPOSITION COMPRISING SAME TYR, CRY2, CRY1 RHOA 3916/4885SYK 1816/4885SIRT2 681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.